跳至主要内容
临床试验/NCT04229316
NCT04229316已完成不适用

Safety And Efficacy Assessment of the zLock Facet Fusion System- A Pilot Study

ZygoFix2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2018年4月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24
试验地点
2
主要终点
Safety assessment - no device related reoperation

研究概览

简要总结

ZygoFix has developed a system consisting of zLOCK Facet Fusion System. The zLOCK Facet Fusion System is intended for single level stabilization of a spinal motion segment to promote bonny fusion of the joint. The system is designed for percutaneous deployment. The zLOCK implant is designed to be deployed in the facet joint thereby utilizing the body's natural mechanical structure without adding an external scaffold (see figure below).

The zLOCK implant is inserted into the facet joint space while it adapts to the joint's changing geometry. Stabilization is achieved by firm grip of each joint bone and resisting to any relative motion. The zLOCK implant is placed percutaneously and requires only one incision per side, thereby reducing the invasiveness, procedure duration and shorten the recovery period.

This pilot study was designed in order to assess the safety and effectiveness of the zLOCK system.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is scheduled for spine surgery with at least one of the following:
  • When used in adjunct to an intervertebral front cage:
  • Degenerative Spondylolisthesis up to grade 2
  • Mild to Moderate Degenerative disc disease (DDD)
  • Degeneration of the facets - following validating the pain source by facet injection.
  • When used stand-alone:
  • Degenerative Spondylolisthesis grade 1-2
  • Moderate to severe Stenosis with listhesis
  • Moderate to severe stenosis without listhesis (in cases that the investigator determines stabilization is required).
  • Degeneration of the facets- following validating the pain source by facet injection.
  • Claudication due to moderate to severe stenosis (central/ foraminal) as verified by imaging.
  • 18< Age < 75
  • Weight < 100Kg
  • Signed informed consent form
  • At least 3 months of unsuccessful conventional treatments

排除标准

  • Fusion procedure performed or required in more than one inter-vertebrae space.
  • Active systemic infection or infection localized to the site of the proposed implantation are contraindications to implantation.
  • Osteoporosis
  • Absence of posterior spinal elements including the pedicle, pars interarticularis, facet joints, spinous process and the majority of the lamina which make it unstable or not possible to place.
  • Any entity or conditions that totally preclude the possibility of fusion, i.e., cancer, kidney dialysis, or osteopenia, are relative contraindications.
  • Obesity (BMI ≥30)
  • Foreign body sensitivity
  • Alcoholism, or drug abuse
  • Subject with a cardiac pacemaker or other implanted electro medical device
  • Subject with known condition of drug abuse and/or alcoholism
  • Women who are either pregnant or nursing at the time of screening (to be verified by test in case of woman of child-bearing potential that do not practice medically acceptable methods of contraception)
  • Concurrent participation in another clinical trial using any investigational drug or device.
  • Mental disorders.

结局指标

主要结局

Safety assessment - no device related reoperation

时间窗: 3 months

The safety of the zLOCK Facet Implant System will be established based on the absence of device related reoperations.

次要结局

  • Efficacy assessment - achieving facet fusion 12 months post procedure(12 months)

研究者

发起方
ZygoFix
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Safety And Efficacy Assessment of the zLock Facet... | 临床试验